Calliditas Therapeutics AB (publ) (CALT)
NASDAQ: CALT · IEX Real-Time Price · USD
21.49
+0.21 (0.97%)
Mar 27, 2024, 12:00 AM EDT - Market open

CALT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current202220212020
Market Capitalization
586502618778
Market Cap Growth
--18.74%-20.55%-
Enterprise Value
578452536657
PE Ratio
-17.53-12.67-11.12-14.72
PS Ratio
5.546.5124.267301.43
PB Ratio
12.466.825.525.27
P/FCF Ratio
-17.69-16.78-11.89-20.64
P/OCF Ratio
-17.69-16.78-12.06-20.64
EV/Sales Ratio
5.465.8621.036162.50
EV/EBITDA Ratio
--11.15-9.74-14.32
EV/EBIT Ratio
-19.45-11.15-9.74-14.32
EV/FCF Ratio
-17.39-15.11-10.30-17.42
Debt / Equity Ratio
1.550.950.210.00
Debt / EBITDA Ratio
--1.73-0.430.00
Debt / FCF Ratio
-2.69-2.34-0.460.00
Quick Ratio
3.494.117.059.43
Current Ratio
3.844.347.489.82
Asset Turnover
0.730.470.160.00
Interest Coverage
-10.12--53.48-6.60
Return on Equity (ROE)
-47.70%-46.50%-45.10%-36.60%
Return on Assets (ROA)
-18.50%-24.20%-34.20%-33.50%
Return on Capital (ROIC)
-20.17%-28.22%-42.94%-31.35%
Earnings Yield
-4.59%-7.89%-8.99%-6.79%
FCF Yield
-4.61%-5.96%-8.41%-4.84%
Buyback Yield / Dilution
-19.28%-18.35%-7.88%-
Total Shareholder Return
-19.28%-18.35%-7.88%-
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).